Audrey Baeyens
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Loss of immune tolerance to IL-2 in type 1 diabetes.
Journal: Nature communications
Published: March 14, 2016
Suppressive activity of human regulatory T cells is maintained in the presence of TNF.
Journal: Nature medicine
Published: January 07, 2016
Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 31, 2015
Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 04, 2015
Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 31, 2014
Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.
Journal: Diabetes
Published: May 15, 2013
Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function.
Journal: Frontiers in immunology
Published: April 30, 2013
Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice.
Journal: Diabetes
Published: February 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026